Free Trial

Rite Aid (RAD) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
50-Day Range
52-Week Range
5,426 shs
Average Volume
4.16 million shs
Market Capitalization
$34.71 million
P/E Ratio
Dividend Yield
Price Target
RAD stock logo

About Rite Aid Stock (NYSE:RAD)

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

RAD Stock News Headlines

Rite Aid bankruptcy bid approved by court
There’s something very “off” about this situation
The stock is now trading for just $10 a share. Why is this company being ignored by Wall Street, and what kind of gains could shareholders soon be looking at?
There’s something very “off” about this situation
The stock is now trading for just $10 a share. Why is this company being ignored by Wall Street, and what kind of gains could shareholders soon be looking at?
See More Headlines
Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Drug stores & proprietary stores
Drug Retail
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$24.09 billion
Book Value
($11.35) per share


Free Float
Market Cap
$34.71 million

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Ms. Elizabeth H. Burr (Age 61)
    Interim CEO & Director
    Comp: $698.46k
  • Mr. Matthew C. Schroeder (Age 53)
    CFO & Exec. VP
    Comp: $822.52k
  • Mr. Steven K. Bixler (Age 44)
    Chief Accounting Officer & Sr. VP
  • Byron Purcell
    VP of Investor Relations & Treasurer
  • Mr. Thomas J. Sabatino Jr. (Age 64)
    Exec. VP & Chief Legal Officer
  • Joy Errico Seusing
    Sr. VP & Chief Communications Officer
  • Ms. Jeanniey Walden
    Sr. VP & CMO
  • Ms. Jessica Kazmaier (Age 49)
    Exec. VP & Chief HR Officer
  • Ms. Karen Lesley Staniforth (Age 62)
    Sr. VP of Clinical Pharmacy Services & Chief Pharmacy Officer
  • Ms. Angele Robinson-Gaylord
    Sr. VP of Store Devel.

RAD Stock Analysis - Frequently Asked Questions

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) released its earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The firm's revenue was up .5% on a year-over-year basis.

When did Rite Aid's stock split?

Shares of Rite Aid reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is Heyward Donigan's approval rating as Rite Aid's CEO?

169 employees have rated Rite Aid Chief Executive Officer Heyward Donigan on Heyward Donigan has an approval rating of 58% among the company's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Does Rite Aid have any subsidiaries?

The following companies are subsidiaries of Rite Aid: Bartell Drugs, Envision Pharmaceutical, RediClinic, Health Dialog, Edgehill Drugs, PCS Health Systems, Harco, and more.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Rite Aid investors own include Century Aluminum (CENX), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF) and Mr. Cooper Group (COOP).

This page (NYSE:RAD) was last updated on 7/12/2024 by Staff

From Our Partners